228 related articles for article (PubMed ID: 16608170)
1. Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of aflatoxin B1.
Kamdem LK; Meineke I; Gödtel-Armbrust U; Brockmöller J; Wojnowski L
Chem Res Toxicol; 2006 Apr; 19(4):577-86. PubMed ID: 16608170
[TBL] [Abstract][Full Text] [Related]
2. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
[TBL] [Abstract][Full Text] [Related]
3. Structure-function relationships of human liver cytochromes P450 3A: aflatoxin B1 metabolism as a probe.
Wang H; Dick R; Yin H; Licad-Coles E; Kroetz DL; Szklarz G; Harlow G; Halpert JR; Correia MA
Biochemistry; 1998 Sep; 37(36):12536-45. PubMed ID: 9730826
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of aflatoxin B1 by normal human bronchial epithelial cells.
Van Vleet TR; Klein PJ; Coulombe RA
J Toxicol Environ Health A; 2001 Aug; 63(7):525-40. PubMed ID: 11497333
[TBL] [Abstract][Full Text] [Related]
5. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
6. Cloning, expression and functional characterization of cytochrome P450 3A37 from turkey liver with high aflatoxin B1 epoxidation activity.
Rawal S; Yip SS; Coulombe RA
Chem Res Toxicol; 2010 Aug; 23(8):1322-9. PubMed ID: 20707407
[TBL] [Abstract][Full Text] [Related]
7. In vitro metabolism of aflatoxin B1 by normal and tumorous liver tissue from Thailand.
Kirby GM; Wolf CR; Neal GE; Judah DJ; Henderson CJ; Srivatanakul P; Wild CP
Carcinogenesis; 1993 Dec; 14(12):2613-20. PubMed ID: 8269634
[TBL] [Abstract][Full Text] [Related]
8. Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes.
Ueng YF; Shimada T; Yamazaki H; Guengerich FP
Chem Res Toxicol; 1995 Mar; 8(2):218-25. PubMed ID: 7766804
[TBL] [Abstract][Full Text] [Related]
9. Modulation of aflatoxin B1 biotransformation in rabbit pulmonary and hepatic microsomes.
Daniels JM; Massey TE
Toxicology; 1992 Aug; 74(1):19-32. PubMed ID: 1514185
[TBL] [Abstract][Full Text] [Related]
10. Activation and detoxication of aflatoxin B1.
Guengerich FP; Johnson WW; Shimada T; Ueng YF; Yamazaki H; Langouët S
Mutat Res; 1998 Jun; 402(1-2):121-8. PubMed ID: 9675258
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation of aflatoxin B1 in rabbit lung and liver microsomes.
Daniels JM; Liu L; Stewart RK; Massey TE
Carcinogenesis; 1990 May; 11(5):823-7. PubMed ID: 2110514
[TBL] [Abstract][Full Text] [Related]
12. Interindividual differences in response to chemoprotection against aflatoxin-induced hepatocarcinogenesis: implications for human biotransformation enzyme polymorphisms.
Eaton DL; Bammler TK; Kelly EJ
Adv Exp Med Biol; 2001; 500():559-76. PubMed ID: 11764998
[TBL] [Abstract][Full Text] [Related]
13. Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone.
Shou M; Korzekwa KR; Brooks EN; Krausz KW; Gonzalez FJ; Gelboin HV
Carcinogenesis; 1997 Jan; 18(1):207-14. PubMed ID: 9054608
[TBL] [Abstract][Full Text] [Related]
14. Determination of aflatoxin B1 biotransformation and binding to hepatic macromolecules in human precision liver slices.
Heinonen JT; Fisher R; Brendel K; Eaton DL
Toxicol Appl Pharmacol; 1996 Jan; 136(1):1-7. PubMed ID: 8560461
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes.
Koehl W; Amin S; Staretz ME; Ueng YF; Yamazaki H; Tateishi T; Guengerich FP; Hecht SS
Cancer Res; 1996 Jan; 56(2):316-24. PubMed ID: 8542586
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of aflatoxin B1 by rabbit and rat nasal mucosa microsomes and purified cytochrome P450, including isoforms 2A10 and 2A11.
Putt DA; Ding X; Coon MJ; Hollenberg PF
Carcinogenesis; 1995 Jun; 16(6):1411-7. PubMed ID: 7788862
[TBL] [Abstract][Full Text] [Related]
17. Mixed inhibition of P450 3A4 as a chemoprotective mechanism against aflatoxin B1-induced cytotoxicity with cis-terpenones.
Zhou Q; Zhang L; Zuniga MA; Tombes RM; Stewart JK
Chem Res Toxicol; 2008 Mar; 21(3):732-8. PubMed ID: 18254608
[TBL] [Abstract][Full Text] [Related]
18. Effect of an extract of the root of Scutellaria baicalensis and its flavonoids on aflatoxin B1 oxidizing cytochrome P450 enzymes.
Kim BR; Kim DH; Park R; Kwon KB; Ryu DG; Kim YC; Kim NY; Jeong S; Kang BK; Kim KS
Planta Med; 2001 Jul; 67(5):396-9. PubMed ID: 11488450
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of aflatoxin B1 in turkey liver microsomes: the relative roles of cytochromes P450 1A5 and 3A37.
Rawal S; Coulombe RA
Toxicol Appl Pharmacol; 2011 Aug; 254(3):349-54. PubMed ID: 21616088
[TBL] [Abstract][Full Text] [Related]
20. Influence of P450 3A4 SRS-2 residues on cooperativity and/or regioselectivity of aflatoxin B(1) oxidation.
Xue L; Wang HF; Wang Q; Szklarz GD; Domanski TL; Halpert JR; Correia MA
Chem Res Toxicol; 2001 May; 14(5):483-91. PubMed ID: 11368545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
